Tissue-directed antibodies and methods of using the same
US-2024342260-A1 · Oct 17, 2024 · US
against Fc-receptors, e.g. CD16, CD32, CD64 (CD23 C07K16/2851)
against Fc-receptors, e.g. CD16, CD32, CD64 (CD23 C07K16/2851) · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/283 |
| Official title | {against Fc-receptors, e.g. CD16, CD32, CD64 (CD23 C07K16/2851)} |
| Display label | against Fc-receptors, e.g. CD16, CD32, CD64 (CD23 C07K16/2851) |
| Total patents | 1,053 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 49 |
| 2016 | 68 |
| 2017 | 58 |
| 2018 | 69 |
| 2019 | 95 |
| 2020 | 103 |
| 2021 | 125 |
| 2022 | 120 |
| 2023 | 106 |
| 2024 | 122 |
| 2025 | 118 |
| 2026 | 20 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Chimeric antigen receptors targeting g-protein coupled receptor and uses thereof
US-2024294599-A1 · Sep 5, 2024 · US
Bifunctional chelators and conjugates
US-2024254092-A1 · Aug 1, 2024 · US
Cd16a binding agents and uses thereof
US-2024051966-A1 · Feb 15, 2024 · US
Immunoglobulin constant region Fc receptor binding agents
US-9512210-B2 · Dec 6, 2016 · US
OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
US-2016347837-A1 · Dec 1, 2016 · US
Fc receptor binding proteins
US-2016222108-A1 · Aug 4, 2016 · US
Fc receptor binding proteins
US-2016194397-A1 · Jul 7, 2016 · US
Human neonatal Fc receptor antibodies and methods of use thereof
US-9359438-B2 · Jun 7, 2016 · US
Methods and compositions for inhibiting cd32b expressing cells
US-2016122435-A1 · May 5, 2016 · US
Interferon lambada-antibody complexes
US-9272029-B2 · Mar 1, 2016 · US
Glucagon/glp-1 receptor co-agonists
US-2015376256-A1 · Dec 31, 2015 · US
Method for diagnosing breast cancer by detection of polymeric immunoglobulin receptor in vesicles isolated from patients
US-9213029-B2 · Dec 15, 2015 · US
Anti-cd20 glycoantibodies and uses thereof
US-2015344585-A1 · Dec 3, 2015 · US
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
US-2015344574-A1 · Dec 3, 2015 · US
Heterodimerized polypeptide
US-2015344570-A1 · Dec 3, 2015 · US
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
US-2015344575-A1 · Dec 3, 2015 · US
Anti-her2 glycoantibodies and uses thereof
US-2015344587-A1 · Dec 3, 2015 · US
Optimized Fc variants and methods for their generation
US-9193798-B2 · Nov 24, 2015 · US
Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
US-2015322152-A1 · Nov 12, 2015 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/283?
- CPC C07K16/283 is the Cooperative Patent Classification code for “against Fc-receptors, e.g. CD16, CD32, CD64 (CD23 C07K16/2851).”
- How many patents are filed under CPC C07K16/283 (against Fc-receptors, e.g. CD16, CD32, CD64 (CD23 C07K16/2851))?
- Our database includes 1,053 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/283 growing?
- Publication counts under this code: 122 in 2024 vs 118 in 2025 (latest complete years).